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Dopamine (DA) modulates the effects of amino acid neurotransmitters (AANs), including
GABA and glutamate, in motor, visual, olfactory, and reward systems (Hnasko et al.,
2010; Stuber et al., 2010; Hnasko and Edwards, 2012). The results suggest that
DA may play a similar modulatory role in the auditory pathways. Previous studies
have shown that deafness results in decreased GABA release, changes in excitatory
neurotransmitter levels, and increased spontaneous neuronal activity within brainstem
regions related to auditory function. Modulation of the expression and localization of
tyrosine hydroxylase (TH; the rate limiting enzyme in the production of DA) in the IC
following cochlear trauma has been previously reported (Tong et al., 2005). In the current
study the possibility of co-localization of TH with AANs was examined. Changes in
the gene expression of TH were compared with changes in the gene expression of
markers for AANs in the cochlear nucleus (CN) and inferior colliculus (IC) to determine
whether those deafness related changes occur concurrently. The results indicate that
bilateral cochlear ablation significantly reduced TH gene expression in the CN after 2
months while in the IC the reduction in TH was observed at both 3 days and 2 months
following ablation. Furthermore, in the CN, glycine transporter 2 (GLYT2) and the GABA
transporter (GABAtp) were also significantly reduced only after 2 months. However, in
the IC, DA receptor 1 (DRDA1), vesicular glutamate transporters 2 and 3 (VGLUT2,
VGLUT3), GABAtp and GAD67 were reduced in expression both at the 3 days and 2
months time points. A close relationship between the distribution of TH and several of
the AANs was determined in both the CN and the IC. In addition, GLYT2 and VGLUT3
each co-localized with TH within IC somata and dendrites. Therefore, the results of the
current study suggest that DA is spatially well positioned to influence the effects of AANs
on auditory neurons.
Keywords: cochlear ablation, tyrosine hydroxylase, cochlear nucleus, inferior colliculus, Sprague–Dawley rat,
hearing loss, real time PCR, immunocytochemistry
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Introduction
Dopamine (DA), a monoamine neurotransmitter, has indirect
eﬀects on synaptic transmission by modulating neural circuits
that contain classical neurotransmitters such as GABA, glycine,
and glutamate. One way these neuromodulatory eﬀects can be
achieved is through co-release of DA and other neurotransmitters
from a single neuron. Dopaminergic neurons have been
reported throughout the hypothalamus, midbrain, and brainstem
including the inferior colliculus (IC; Holt et al., 2005; Tong et al.,
2005). In the peripheral auditory system DA has been reported
to play a neuroprotective role. Speciﬁcally, lateral olivocochlear
(LOC) neurons have been implicated in the protection of inner
hair cells from excitotoxic damage (Puel et al., 2002; Darrow
et al., 2006a,b, 2007). Immunoreactivity for tyrosine hydroxylase
(TH), the rate limiting enzyme in DA biosynthesis, is decreased in
LOC neurons following noise induced deafness while noise pre-
conditioning seems to prevent this change (Canlon et al., 1988;
Niu and Canlon, 2002; Niu et al., 2004a,b).
In the central auditory system, little is known about the
role of DA in normal hearing or the eﬀects of DA on plastic
changes observed following trauma. Expression for TH is
decreased in the IC for up to 3 months following cochlear
ablation (Holt et al., 2005). Depending upon the IC subdivision
examined, deafness related decreases in TH production (not
dopamine beta hydroxylase (DBH) or phenylethanolamine-N-
methyl transferase (PNMT)) can be either transient (days to
weeks) or long lasting, i.e., months (Tong et al., 2005).
In addition to DA, neurons throughout the central auditory
pathways are also known to produce GABA, glutamate and
glycine. Similar to changes in TH levels, these amino acid
neurotransmitters (AANs) are modulated as a consequence of
cochlear trauma (Bledsoe et al., 1995; Milbrandt et al., 2000;
Suneja et al., 2000; Vale and Sanes, 2002; Buras et al., 2006;
Altschuler et al., 2008; Dong et al., 2010; Fyk-Kolodziej et al.,
2011;Wang et al., 2011) implicating diﬀerent eﬀects on ascending
versus descending and auditory versus non-auditory pathways.
For example, in the IC, glutamic acid decarboxylase (GAD),
the rate-limiting enzyme for GABA production, is decreased
following deafness and deafness related conditions. In the
cochlear nucleus (CN) the primary inhibitory neurotransmitter
is glycine and deafness results in signiﬁcantly reduced glycine
levels (Asako et al., 2005). Expression and localization of vesicular
glutamate transporters, VGLUT1-3, also change in the CN in
response to deafness (Fyk-Kolodziej et al., 2011). In the superior
olivary complex following deafness glycine (Buras et al., 2006) is
also reduced. Since DA in several neuronal systems can be co-
localized with various transmitters (Schimchowitsch et al., 1991;
Gonzalez-Hernandez et al., 2001; Zhou et al., 2005; Darrow et al.,
2006b; Maher and Westbrook, 2008; Hnasko et al., 2010; Stuber
et al., 2010; Tecuapetla et al., 2010; Hirasawa et al., 2012; Hnasko
and Edwards, 2012; Stensrud et al., 2014), this raises the question
of whether DA in the auditory system is co-localized with AANs
in the IC and/or the CN and whether the time course and
direction of changes in DA and AAN levels correlate following
deafness. In the current study, deafness related gene expression
levels and co-localization of TH with markers for GABA, glycine,
and glutamate are examined in the CN and IC to determine likely
AAN candidates for the neuromodulatory actions of DA.
Materials and Methods
Animals
Speciﬁc pathogen-free adult male Sprague–Dawley Rats (Charles
River, Wilmington, MA, USA) were used in accordance with
the Institutional Animal Care and Use Committee (IACUC) at
Wayne State University School of Medicine and conformed to
guidelines issued by the National Institutes of Health and the
Society for Neuroscience.
Hearing Assessment
Hearing was assessed by ABR measures at 4, 12, and 20 kHz
at the beginning of the study and those with hearing in the
normal range (15–35 dB across frequencies) were included in
the study. A second measure of hearing was done just prior to
perfusion for animals in the deafness groups. At least a 65 dB
shift from the normal control threshold averaged across the
frequencies was considered necessary for continued inclusion in
the study. Once animals were anesthetized (xylazine −8 mg/kg
and ketamine −75 mg/kg) and placed in a sound proof booth
(Hamilton–Kinder, Poway, CA, USA), three frequencies (4, 12,
and 20 kHz) were tested using a speaker placed directly into the
ear canal (Beyer sound source and Pyramid PA 600x stereo power
ampliﬁer). The active electrode (on top of the head), reference
needle (below the recording ear) and ground (the contralateral
ear) were properly placed. The sound stimulus consisted of a
15-ms tone burst, with a rise–fall time of 1 ms. Waveforms
were visualized and recorded using the Data AcQusition and
Real-Time Analysis (Daqarta 4.0) software package (Interstellar
Research, Ann Arbor, MI, USA). The sound stimulus was started
at 80 dB SPL and, in the hearing group, was decreased in 10 dB
SPL steps until near threshold, then in 5 dB SPL increments until
threshold could be determined. For each level, 1024 responses
were averaged.
Deafening Procedure
Each rat in the deafened group was anesthetized with, i.m.,
injections of xylazine (8 mg/kg) and ketamine (75 mg/kg). Local
injections of 1% Lidocaine–HCl solution were made at the site
of each surgical incision. Surgical procedures were performed
under aseptic conditions. The skin incision was made through
the post auricular region of the lateral neck. The bulla was
exposed, opened and the organ of Corti was destroyed with
a dental pick. The bulla was then sealed with dental cement
(Durelon, Etgen, Germany) and the skin incision was closed with
sutures. Following surgery, animals were injected with sterile
0.9% sodium chloride solution (1–3 ml s.c.) and allowed to
recover on a heating pad.
Real Time RT-PCR (qRT-PCR)
Under sodium pentobarbital anesthesia (90 mg/kg, i.p.), the CN
and IC were rapidly dissected from 24 normal hearing rats,
12 rats at 3 days post-deafening and 12 rats at 2 months post
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deafening and placed in RNA Later (Applied Biosystems, Foster
City, CA, USA). For each group the 12 rats were divided into
four pools containing three rats each with age matched normal
hearing controls for each deafened group. The RNA was then
isolated as described in Holt et al. (2005). Brieﬂy, RNA extraction
was achieved by Trizol using Phase Lock (heavy) Gel tubes
(Eppendorf). The concentration of RNA was quantiﬁed using
A260 UV spectrophotometry and the quality of the RNA was
veriﬁed by Agilent analysis (Applied Biosystem, Foster City, CA,
USA). For each RNA sample 2 μg were used for cDNA synthesis
(High Capacity cDNA Archive Kit). Real time RT-PCR was
performed with a Mastercycler R©ep Realplex (Eppendorf) using
TaqMan Gene Expression Assays (Applied Biosystems, Foster
City, CA, USA). In this study the Ct was established automatically
using the Realplex software.
Thus, expression for: TH, vesicular glutamate transporter
1 (VGLUT1), vesicular glutamate transporter 2 (VGLUT2),
vesicular glutamate transporter 3 (VGLUT3), GABA transporter
protein (GABAtp), GABA vesicular transporter1 (VGAT),
glutamic acid decarboxylase2 (GAD 65), glutamic acid
decarboxylase1 (GAD 67), glycine transporter1 (GLYT1),
glycine transporter2 (GLYT2), and GABA A receptor beta1
(GABRB1) was examined across groups with hypoxanthine
phosphoribosyltransferase 1 (HPRT1), a housekeeping gene,
used for qRT-PCR normalization. Each sample was run using the
conditions described in Fyk-Kolodziej et al. (2011). Ampliﬁcation
eﬃciency was tested and calculated [eﬃciency (%) = 10−1/slope –
1] for each assay in each brain region. Since the ampliﬁcation
eﬃciency was similar between the housekeeping gene and the
genes of interest, the 2−(ct) method and a two tailed t-test
were used to quantify diﬀerential expression and determine
signiﬁcance (p ≤ 0.05). SD range was determined and applied
as outlined in the technical note released by applied biosystems
(www3.appliedbiosystems.com/cms/groups/mcb_support/docu
ments/generaldocuments/cms_042380.pdf) resulting in non-
symmetrical error bars.
Immunocytochemistry
Each antiserum has been characterized in previous studies
(Table 1). To determine the normal distribution and co-
localization of TH with VGLUT1, VGLUT3, GAD67, and
GLYT2 in the CN and the IC, normal hearing (n = 8) and
deafened (n = 9; bilateral cochlear ablation) speciﬁc pathogen-
free male Sprague–Dawley Rats were separated into three groups
corresponding to time following hearing loss (no surgery-normal
hearing, 3 days after surgery-3 day deaf, 2 months after surgery-
2 month deaf). Animals were perfused transcardially with 4%
paraformaldehyde. Once removed, the brains were post-ﬁxed for
an hour in the same solution and cryo-protected in 20% sucrose
for 24 h at 4◦C. Frozen brains were cut into 40 μm sections
using a freezing sliding microtome and collected serially into
12 vials. Sections containing the CN and IC were incubated for
48 h at 4◦C with the primary antibody (TH rabbit polyclonal
antibody 1:1500–1:2000, GAD67 mouse monoclonal antibody
1:1000, GLYT2 guinea pig polyclonal antibody 1:1000, VGLUT1
guinea pig polyclonal antibody 1:1000, VGLUT3 guinea pig
polyclonal antibody 1:1000 (Chemicon, Temecula, CA, USA),
VGLUT3 mouse monoclonal antibody 1:100 (NeuroMab, Davis,
CA, USA), DBH mouse monoclonal antibody 1:400, and PNMT
mouse monoclonal antibody 1:2000 (Chemicon, Temecula, CA,
USA). Following three rinses sections were incubated for 2 h with
the appropriate ﬂuorescent secondary antibody (either donkey
anti-rabbit FITC, goat anti-guinea pig Texas Red, or rabbit anti-
mouse Texas Red 1:500; Jackson ImmunoResearch Laboratories).
Image Processing and Analysis
Images were examined using a Leica DM4500 microscope
equipped with appropriate band pass ﬂuorescent ﬁlters. Images
TABLE 1 | Antibodies.
Antiserum/Immunogen Species Source/Cat. No. Dilution Reference
Tyrosine hydroxylase (TH) from rat
pheochromocytoma
Rabbit Chemicon,Temecula, CA AB152, USA 1:1500–1:2000 Trigueiros-Cunha et al. (2003)
VGLUT1
Amino acids 541–560 of rat
VGLUT1
Guinea pig Chemicon, Temecula, CA AB5905, USA 1:1000 D’Sa et al. (2007), Brooke et al.
(2010), Fyk-Kolodziej et al. (2011)
VGLUT3
Synthetic peptide from rat VGLUT3
Guinea pig Chemicon, Temecula, CA AB55421, USA 1:1000 Seal et al. (2008), Henny et al.
(2010), Fyk-Kolodziej et al. (2011)
VGLUT3








Mouse Chemicon, Temecula, CA MAB5406, USA 1:1000 Burianova et al. (2009), Brooke
et al. (2010)
Glycine transporter 2
Synthetic peptide from rat
C-terminus GLYT2





Sheep Chemicon,Temecula, CA AB146, USA 1:2000 Long et al. (2005)
DBH
Purified bovine DA beta hydoxylase
Mouse Chemicon, Temecula, CA MAB308, USA 1:400 Trigueiros-Cunha et al. (2003), Long
et al. (2005), Drescher et al. (2006)
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were taken using a Photometrics Coolsnap EZ, 12 bit, 20 MHz
monochrome digital camera (Maeger Scientiﬁc, Ann Arbor, MI,
USA). To analyze data from images, NIS Elements Software
(Nikon) was used to identify and determine the density of labeled
terminals and cells. For density analysis, the density of labeled
TH ﬁbers and cells for each region analyzed was determined
bilaterally in three diﬀerent sections separated by at least 120 μm
across animals in normal hearing as well as 3 days and 2 months
deaf animals. The results are reported as a scaled ratio per μm2.
Student’s t-test was used to determine signiﬁcant diﬀerences
(p ≤0.05).
Results
Deafness Related Differential Expression of
Tyrosine Hydroxylase and Amino Acid
Neurotransmitter Related Genes
Cochlear Ablation Results in Profound Hearing Loss
Auditory brainstem responses were analyzed before and after
cochlear ablation. Average thresholds for normal hearing animals
were 30 dB at 4 kHz (SD ± 5.04), 28 (SD ± 2.45) dB at
12 kHz, and 30 dB at 20 kHz (SD ± 4.15). At 3 days and
2 months following cochlear ablation, hearing thresholds were
not detectable up to 100 dB (the loudest level tested at each
frequency). The results suggest that the surgery was successful in
each case assessed.
Cochlear Damage Results in Temporal Correlation of
Tyrosine Hydroxylase and Inhibitory Neurotransmitter
Related Gene Expression in the CN
To determine whether the pattern of diﬀerential expression of
DA parallels that of AANs related genes, the relative expression
level for TH and DA receptors was compared, with that of GABA,
glycine, and glutamate related genes by qRT-PCR in the CN
and IC (Figures 1 and 2) at two time points following cochlear
ablation. For the CN TH was signiﬁcantly decreased (Figure 1A)
only at the 2 months time point (mean: 0.65, p = 0.0032). Of
the 14 other neurotransmitter related genes tested, only GABAtp
(mean: 0.87, p= 0.0110) andGLYT2 (mean: 0.58, p= 0.0071) had
a similar change in expression (Figures 1B,C), decreasing only at
the 2 months time point following cochlear ablation. However,
FIGURE 1 | Dopamine (DA) and amino acid neurotransmitter (AAN)
related genes are differentially expressed in the cochlear nucleus
(CN). Changes were assessed in DA related (A), inhibitory (B,C) and
excitatory (D) AAN related gene expression in the CN, 3 days and 2 months
following bilateral cochlear ablation. Although TH gene expression levels were
not changed at the 3 day time point, expression was significantly decreased
by 2 months (35%; A). Only two other genes, GABAtp and GLYT2, both
inhibitory, had a similar pattern of expression, significant decreases by
2 months, 13 and 42%, respectively. Three days of deafness resulted in DA
receptor Drd5, being significantly increased (42%) while Drd3 and VGLUT2
were significantly decreased by 28% (A) and 37% (D), respectively. Only
gene expression of GABArb1 was significantly changed at both time points
with 20% (3 days) and 32% (2 months) decreases were observed. Error
bars: SD; asterisk: p ≤ 0.05.
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FIGURE 2 | Dopamine and AAN related genes are differentially
expressed in the inferior colliculus (IC). Changes were assessed in
DA related (A), inhibitory (B,C), and excitatory (D) AAN related gene
expression in the IC 3 days and 2 months following bilateral cochlear
ablation. TH expression decreased significantly in the IC at both 3 days
(31%) and 2 months (38%). In addition to the DA receptor subunit,
Drd1A (15%-3 days; 23%-2 months; A), four AAN related genes showed
the same pattern of expression as TH: significant decreases at both time
points. Of these, two were related to excitatory neurotransmission
(VGLUT2: 60%-3 days and 32%-2 months; VGLUT3: 62%-3 days and
52%-2 months) and two related to inhibitory neurotransmission (GABAtp:
15%-3 days and 22%-2 months; GAD67: 29%-3 days and
36%-2 months). Interestingly, seven genes were significantly decreased
(Drd2-30%; Drd5:-18%; GLYT1- 31%; GLYT2- 45%; GAD65- 22%;
GABArb1- 26%) only at the 2 months time point (A,C,D). Error bars: SD;
asterisks: p ≤ 0.05.
four other neurotransmitter related genes also showed signiﬁcant
changes in expression.
Expression of DA receptor Drd3 (mean: 0.72, p = 0.00275)
was signiﬁcantly decreased, while Drd5 was signiﬁcantly
increased (mean: 1.48, p = 0.00384), 3 days following ablation
(Figure 1A). The expression of VGLUT2 was signiﬁcantly
decreased (Figure 1D) only at the 3 days time point (mean:
0.63, p = 0.00011) while GABRB1 was the only gene signiﬁcantly
decreased (Figure 1B) at both 3 days (mean: 0.80, p = 0.0145)
and 2 months (mean: 0.68, p = 0.0143) following cochlear
damage.
Cochlear Damage Results in Temporal Correlation of
Tyrosine Hydroxylase and both Excitatory and
Inhibitory Neurotransmitter Related Gene Expression
in the IC
In accord with previous results (Holt et al., 2005; Tong et al.,
2005) signiﬁcant decreases were observed in the level of TH in
the IC both at 3 days (mean: 0.69, p = 0.022) and 2 months
(mean: 0.62, p = 0.014) following cochlear damage (Figure 2A).
Five of the other genes tested were also signiﬁcantly decreased
at both time points, including DA receptor Drd1A (Figure 2A;
3 days mean: 0.85, p = 0.007; 2 months mean: 0.77, p = 0.028)
genes related to inhibitory neurotransmission (Figure 2B),
GAD67 (3 days mean: 0.71, p = 0.0123; 2 months mean:
0.64, p = 0.001) and GABAtp (3 days mean: 0.85, p = 0.034;
2 months mean: 0.78, p = 0.006), as well as those related to
excitatory neurotransmission (Figure 2D), VGLUT2 (3 days
mean: 0.40, p= 4.5× 10−9; 2 months mean: 0.68, p= 0.029) and
VGLUT3 (3 days mean: 0.38, p = 0.035; 2 months mean: 0.48,
p = 0.049). There were additional genes for which expression
was decreased only at the 2 months time point. These include
DA receptors (Figure 2A), Drd2 (mean: 0.70, p = 0.010), Drd3
(mean: 0.79, p = 0.054), and Drd5 (mean: 0.82, p = 0.038)
as well as those genes related to inhibitory neurotransmission
(Figures 2B,C), GABRB1 (mean: 0.74, p= 0.017), GAD65 (mean:
0.78, p = 0.0004), as well as GLYT1 (mean: 0.69, p = 0.011) and
GLYT2 (mean: 0.55, p = 0.003).
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Differential Localization and Distribution of
Tyrosine Hydroxylase and Amino Acid
Neurotransmitter Related Proteins Following
Hearing Loss
Controls
Antibodies for each of the proteins assessed have either been
previously veriﬁed (Table 1) or were veriﬁed during the course
of the current study. The speciﬁcity of antibodies for VGLUT1,
VGLUT2, and VGLUT3 in the DCN and VCN (Fyk-Kolodziej
et al., 2011) as well as VGLUT1 and VGLUT2 in the IC
(Altschuler et al., 2008) have been previously veriﬁed. In the
FIGURE 3 | In the IC VGLUT3 is expressed and produced. Gene
expression for VGLUT3 in the IC was demonstrated using PCR (A), with a
predicted band of approximately 1.9 kb. Western blotting for VGLUT3 protein
in the IC resulted in a single band ∼65 kDa (B).
IC, speciﬁcity for VGLUT3 was veriﬁed using several methods.
First, speciﬁc primers were designed for PCR veriﬁcation of
VGLUT3 in the IC. Similar to previous results in the DCN,
VCN, and auditory cortex, a band of predicted size (∼1.9 kb)
was identiﬁed spanning the entire coding region (Figure 3A).
The PCR products were cloned and sequence veriﬁed. No splice
variants were identiﬁed. This suggests that a single VGLUT3
isoform is present in the IC. In addition, Western blotting
(Figure 3B) resulted in a single band of the expected size
(∼65 kD). Preadsorption of the VGLUT3 antibody with the
targeted antigen resulted in great diminution of immunolabeling.
Just as in the CN, two diﬀerent VGLUT3 antibodies were used,
The pattern of immunolabeling was the same for both antibodies.
Taken together the gene expression and immunohistochemistry
data provide evidence that neurons in the IC express and produce
VGLUT3.
In the CN the ﬁrst step was to determine whether
dopaminergic somata and terminals are found in the DCN and
AVCN. The rate-limiting enzyme, TH, was used as a marker
for DA. The catecholaminergic transmitters DA, nor-adrenaline,
and adrenaline are synthesized through a common pathway.
There are several enzymes that are part of the biosynthetic
machinery including: phyenylalanine hydroxylase, TH, aromatic
Dopa decarboxylase (ADC), dopamine β hydroxylase (DBH),
pteridine reductase, and PNMT. When compared to DBH
and PNMT, labeling of a neuron for TH only indicates DA
production, while labeling of a neuron for TH and DBH indicates
adrenaline or noradrenaline, and a neuron that is positive for TH,
DBH, and PNMT would be expected to produce adrenaline. In
the AVCN, while there were many ﬁbers labeled only for TH,
there were ﬁbers that co-labeled for both TH and DBH (data
not shown). In addition, as previously reported in the IC (Tong
FIGURE 4 | Co-localization of TH and DBH in the IC reveals three types
of labeling. In the external cortex of the inferior colliculus (ECIC) labeling for TH
(red) and TH + DBH (yellow) is observed throughout the nucleus (A). The
majority of fibers and terminals in the deeper layers of the ECIC were
co-localized for DBH and TH (e.g., arrows) and occasional labeling for fibers
containing only TH were observed (A’–A”’). In the more superficial layers of the
ECIC labeling for TH is predominant (A). In the dorsal cortex of the IC (DCIC)
labeling for TH and DBH was observed throughout the subdivision (B). There
were somata, fibers and terminals that labeled only for TH (red), some fibers that
labeled for both TH and DBH (yellow) and a population of fibers that appeared
to label only for DBH (B’–B”’). Asterisk: somata labeled only for TH Scale bar:
20 μm.
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FIGURE 5 | In the AVCN the majority of GAD67 (green) has a distribution
that is distinct from TH (red). While GAD67 is primarily localized to organized
axosomatic GABAergic terminals (B,B’), TH on the other hand, appears to be
localized both to dendrites and axon terminals (A,C). Two months after
deafness was induced, GAD67 labeling is increased in the granule cell region
and the distribution to larger terminals forming axosomatic rings is disrupted
(D,D’). Arrows (B’) and arrowheads (D’) indicate representative areas of
potential GAD67 and TH contact. Scale bar: 20 μm.
et al., 2005), the majority of TH positive somata are DBHnegative
(Figure 4). However, three diﬀerent populations of ﬁbers were
observed. In both the DCIC and ECIC, ﬁbers labeled for TH
only were predominant in the most dorsal layers (Figures 4A,B).
Fibers co-labeled for both TH and DBH were primarily found
in the ventral ECIC (Figures 4A’–A”’). The majority of ﬁbers
in the more ventral regions of the DCIC labeled for DBH only
(Figures 4B’–B”’).
Localization of Tyrosine Hydroxylase in the CN and IC
Following Cochlear Damage
AVCN
In normal hearing animals modest labeling for TH was
distributed throughout the AVCN, including the granule cell
region (Figure 5A, red). Labeling for TH was observed primarily
in en passant ﬁbers throughout the nucleus. Two months
following cochlear ablation, the overall density of TH labeling was
decreased by 17% in the AVCN (Figure 5C).
DCN
Labeling for TH is also observed throughout the DCN
(Figure 6A) with labeling for ﬁbers most sparse in the molecular
layer (DCN-M). Following 2 months of deafness the general
density of TH labeling changes, with less labeling in the neuropil
and more labeling in boutons and ﬁbers of passage (Figure 6C).
The change in density of TH labeling is fairly uniform, observed
in the superﬁcial DCN-M, the fusiform layer (DCN-F) as well as
the deep layer (DCN-D) of the DCN, (Figure 6C).
Inferior Colliculus
Several studies have reported the distribution of TH in the IC
(Holt et al., 2005; Tong et al., 2005; Hormigo et al., 2012). In
normal hearing rats, the most robust labeling for TH positive
somata is in the dorsal portion of the caudal DCIC, while rich
immunolabeling for ﬁbers and terminals is found throughout the
IC. Following hearing loss diﬀerential labeling of TH has been
reported within subdivisions of the IC at diﬀerent times following
cochlear damage. (Holt et al., 2005; Tong et al., 2005). The results
of the present study are consistent with these previous results
found after 3 months of induced deafness. In the current study
TH labeling is decreased in the IC at the 2 months time point
(data not shown).
Co-Localization of TH and Amino Acid
Neurotransmitters in the CN Following
Cochlear Damage
Co-immunolabeling for TH and GAD67 in the
Cochlear Nucleus Reveals a Largely Complementary
Distribution
AVCN
While TH labeling (red) is localized to both dendrites and
axon terminals, GAD67 (green) is prominent within GABAergic
terminals (Figures 5B,B’) with axosomatic proﬁles surrounding
(a ring of greater than ten GAD67 proﬁles) immunonegative
somata. 2 months following induced deafness the density of
GAD67 labeling is not changed (normal: 1.15 ±0.07; deaf:
1.21 ± 0.06). However, axosomatic labeling, as demonstrated
by organized perisomatic rings (Figures 5B,B’, D,D’) decreases
(normal: 19 ± 1.7; deaf: 9 ± 2.8), replaced with a more
disorganized, diﬀuse axodendritic labeling within the neuropil. In
addition, more robust GAD67 labeling is observed in the granule
cell region (Figure 5D) with labeling in this region increasing by
50%. Although very little co-localization of TH and GAD67 was
observed in normal hearing animals (Figures 5B,B’), there was
a close association of TH and GAD67, in both the normal and
deaf groups (Figures 5B,B’, D,D’). Following 2months of induced
deafness GAD67 is localized to smaller immuno-positive proﬁles.
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DCN
In normal hearing animals, perisomatic, and somatic labeling
for GAD67 was observed in all layers of the DCN (Figure 6B),
with labeling in the dorsal most portion of the DCN-M being
most sparse and labeling in more ventral DCN-M and the
DCN-F layer being most dense. In the DCN-D, the heaviest
GAD67 labeling is localized to the most ventral portion of the
region. Following deafness, GAD67 labeling in the DCN-M was
enhanced. However, in the DCN-F labeling was less intense and
more diﬀuse. In the DCN-D labeling was diminished. Very few
sites of possible TH and GAD67 interaction were observed under
normal hearing conditions (Figure 6B) or following cochlear
damage (Figure 6D).
Immunolabeling for TH and Glycine Transporter 2
(GLYT2) in the Cochlear Nucleus Appears Less
Robust Following Cochlear Damage
AVCN
In normal hearing subjects, GLYT2 labeled terminals were
distributed throughout the AVCN and localized to both
large (>1.50 μm) and small (0.4–1.5 μm) axosomatic
terminals (Figures 7A,A’). Many of the TH and GLYT2
positive terminals appeared to be in close apposition
(Figures 1–3 and 7A’). Hearing loss shifted labeling
of GLYT2 axon terminals primarily to small terminals
(Figures 7B,B’). Also fewer perisomatic GLYT2 labeled
terminals were apparent. Nonetheless, a robust interaction
(possible contact) persisted between TH positive ﬁbers and
the remaining GLYT2 perisomatic terminals (Figures 1
and 7B’).
DCN
Although immunolabeling for GLYT2 was distributed
throughout all three layers of the DCN (Figure 8A), the
bulk of the labeling was in the molecular and fusiform layers.
Cochlear damage resulted in a decrease in GLYT2 labeling
throughout the DCN, but with a particularly dramatic decrease
in GLYT2 observed in DCN-M and DCN-D (Figure 8B).
Co-localization and/or possible contact between TH and
GLYT2 was noted (Figure 8A) and did not seem aﬀected by
deafness.
Co-Immunolabeling for TH and Vesicular Glutamate
Transporter 1 (VGLUT1) in the Cochlear Nucleus
Demonstrates a Possible Relationship
AVCN
Just as reported previously (Fyk-Kolodziej et al., 2011), when
there is no substantial cochlear damage, VGLUT1 labeling is
localized to axosomatic and axodendritic terminals throughout
the AVCN (Figures 9A,A’). Severe cochlear damage results
in a dramatic shift in VGLUT1 labeling from terminals to
somata in the core of the AVCN with a pronounced increase in
VGLUT1 labeling in the granule cell domain (Figures 9B,B’).
While no co-localization of TH and VGLUT1 was observed
under normal hearing conditions, there appeared to be possible
contact between VGLUT1 and TH positive boutons (Figures 1–3
FIGURE 6 | In the DCN the GAD67 labeling (green) is distinct from TH
(red) with sparse labeling for TH fibers in DCN-M (A,C) and GAD67 (B,D)
primarily localized to terminals with distinct labeling in ventral DCN-M
and DCN-F. Following deafness GAD67 labeling increases in DCN-M and
DCN-D (D) while for TH labeling there is an increase in DCN-M boutons and a
decrease in the neuropil (C). Fine GAD67 labeled boutons do not extend to the
deepest layers of DCN-D 2 months after deafening. Dotted lines (A) indicate
approximate boundaries between DCN-M, DCN-F, and DCN-D. Scale bar: 50 μm.
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FIGURE 7 | In the AVCN the distribution of GLYT2 (green) overlaps with
TH (red). Labeling for GLYT2 is localized to glycinergic terminals with TH
labeling primarily localized to complimentary terminals and dendrites (A,B)
with a few areas of co-localization (yellow). Following deafness GLYT2 labeling
is decreased. Arrows indicate closely associated puncta. (A’) – an
enlargement of square in (A). (B’) – an enlargement of box in (B). Numbers
and arrow in (A’) and (B’) indicated enlarged regions in (A’,B’) with arrows
showing co-localization (yellow) and close apposition between GLYT2 and TH.
Scale bar: 20 μm.
and 9A’). Following deafness this close association of TH and
VGLUT1 was severely diminished (Figure 9B’), with little
putative contact observed between VGLUT1 somata and TH
positive terminals.
DCN
Labeling of VGLUT1 has been reported in the DCN (Zhou et al.,
2007; Fyk-Kolodziej et al., 2011). Labeling for VGLUT1 is found
within terminals in all three layers of the DCN (Figures 10A,A’),
with the heaviest labeling in the molecular layer (DCN-M).While
synaptic contact between and/or co-localization of VGLUT1 and
TH in the molecular layer may be expected, the density of
VGLUT1 labeling precluded us obtaining clear evidence of such
interactions. Deafness resulted in diﬀuse VGLUT1 labeling in
DCN-F and DCN-D with few VGLUT1 TH points of contact
(Figures 10B,B’).
Co-localization of TH and Amino Acid
Neurotransmitters in the IC
Co-Immunolabeling for TH and GAD67 in the Inferior
Colliculus Reveals a Largely Complementary
Distribution
The central nucleus (CNIC), external cortex (ECIC), and
dorsal cortex (DCIC) of the IC were examined for co-
localization of TH and GAD67 (Figure 11). Labeling
for GAD67 was observed in somata and axon terminals
throughout the CNIC (Figures 11A,A’). Interspersed
FIGURE 8 | In the DCN, GLYT2 labeling is robust throughout most of
the DCN. While both GLYT2 (green) and TH (red) labeling is localized to
dendrites and terminals (A,B), the labeling is primarily complimentary.
Following deafness GLYT2 labeling is dramatically decreased in each layer of
the DCN, especially in DCN-M and DCN-D. Arrowheads indicate regions of
TH and GLYT2 interaction enlarged at arrows. Scale bar: 50 μm.
amongst the GAD67 labeled somata and axon terminals,
TH labeled ﬁbers were found to be in very close proximity
to GAD67 terminals (Figure 11A’ – enlargements). This
same pattern of GAD67 labeling was observed in the DCIC
(Figures 11C,C’). However, in the ECIC, while GAD67 labeling
was present through the region, layer two had noticeably
less labeling (Figures 11B,B’). Although sparse, occasional
co-localization of GAD67 and TH was observed in en passant
swellings in the ECIC and the DCIC (see enlargements in
Figures 11B’,C’).
Immunolabeling for TH and GLYT2 in the Inferior
Colliculus is Co-Localized
Somata and terminals immunopositive for GLYT2 were
distributed throughout the CNIC, ECIC, and DCIC.
Interestingly, the CNIC contained the most sparse labeling
of GLYT2 somata and the greatest density of GLYT2 terminals,
which was localized to the ventral CNIC (Data not shown).
Co-localization of GLYT2 with TH within somata was observed
in both the DCIC (Figures 12A–A”) and the ECIC (Data not
shown).
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FIGURE 9 | Vesicular Glutamate Transporter 1 (green) is found in the
anteroventral cochlear nucleus (AVCN) with a distribution largely
distinct from TH (red). In normal hearing animals labeling for VGLUT1 is
primarily localized to large glutamatergic terminals (A,A’) forming
axosomatic ring structures throughout the nucleus (A,B). While VGLUT1
positive terminals are in close contact with TH positive en passant
swellings (A’ 1–3) little to no co-localization was observed. Following
deafness, labeling for VGLUT1 becomes visible within cell bodies and
smaller terminals (B,B’). Scale bar – 5 μm in boxes labeled 1, 2, and 3.
Scale bar: 20 μm (A,A’,B,B’).
FIGURE 10 | In the dorsal cochlear nucleus (DCN) the distribution of
VGLUT1 (green) is distinct from TH (red). In normal hearing animals VGLUT1
is primarily localized to glutamatergic terminals that rarely co-localize with TH
labeled terminals (A). Following deafness VGLUT1 labeling is more diffuse and
less punctate in DCN-F (B,B’). In panels (A’,B’) only the green channel
(VGLUT1) is depicted Scale bar: 50 μm.
Terminals Immunolabeled for TH and VGLUT1 are
Closely Associated in the IC
The distribution of VGLUT1 has previously been reported in
the IC (Altschuler et al., 2008). In the IC, labeling for VGLUT1
was restricted to axon terminals (Figure 13). Within each
subdivision of the IC, VGLUT1, and TH were in close apposition
(Figures 13B,D,F), with VGLUT1 often present along TH labeled
en passant ﬁbers (Figures 13B’,D’,F’).
Vesicular Glutamate Transporter 3 (VGLUT3) is
Distributed Throughout the Inferior Colliculus and
Co-Localized with TH
Although labeling for VGLUT3 was observed in ﬁne terminals
within the IC, the most robust labeling was punctate and
primarily observed within large and small somata (Figure 14).
While VGLUT3 labeling was clearly localized to both somata
and dendrites in the CNIC (Figures 14A,A’) and ECIC
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FIGURE 11 | In the IC GAD67 (green) is distributed throughout
each subdivision and is closely associated with TH labeled (red)
en passant terminals. Terminals labeled for GAD67 in the central
nucleus (CNIC), external cortex (ECIC), and dorsal cortex (DCIC) of
the IC (A–C) are in close contact with TH labeled terminals (A’,B’).
Arrows indicate TH labeled spines studded with GAD67 labeled
puncta. Scale bar: 10 μm in boxes containing arrows. Scale bar:
20 μm (A,A’–C,C’).
FIGURE 12 | In the IC GLYT2 (green) and TH (red) are co-localized. In the DCIC (A–A”) double labeling for TH and GLYT2 was primarily observed in somata
and dendrites. Arrows indicate somatic labeling of GLYT2 and TH. The asterisk indicates a neuron in the DCIC labeled for GLYT2 only (A). DCIC – dorsal cortex of
the IC; Scale bar: 5 μm.
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FIGURE 13 | In the IC VGLUT1 (green) is distributed throughout
each subdivision and is closely associated with TH labeled (red)
terminals. Terminals labeled for TH in the CNIC, ECIC, and DCIC
(A,C,E) appear to be in close contact with VGLUT1 labeled terminals
(B,B’,D,D’,F,F’). Arrows indicate terminals enlarged within boxes in
(B’,D’) and (F’). Boxes in (B,D,F) are enlarged in (B’,D’,F’); Scale
bar: 5 μm for boxes in (B’,D’,F’). Scale bar: 20 μm (A,B,B’,C,D,
D’,E,F,F’).
(Figures 14B,B’), in the DCIC VGLUT3 labeling appeared to be
predominantly conﬁned to somata (Figures 14C,C’) and was less
evident in dendrites. Co-immunolabeling of VGLUT3 and TH
was largely observed in the DCIC (Figure 15). Approximately
25% of the VGLUT3 immunolabeled somata in the DCIC co-
contained TH, primarily in stellate and disk shaped neurons
(Figures 15A–F).
Discussion
In the current study, the distribution of TH in the CN has been
detailed and previous work demonstrating the presences of TH
in the IC has been substantiated (Holt et al., 2005; Tong et al.,
2005; Hormigo et al., 2012; Gittelman et al., 2013). Described for
both the CN and the IC, are deafness (cochlear ablation) induced
temporal changes in gene expression for TH, DA receptors and
genes related to AANs (Tables 2 and 3). The current study adds
to growing evidence supporting the presence of endogenous DA
and dopamine receptors reported in the CN and IC (Wamsley
et al., 1989; Weiner et al., 1991; Holt et al., 2005; Tong et al., 2005;
Bender et al., 2010, 2012; Hormigo et al., 2012;Maison et al., 2012;
Gittelman et al., 2013; de Oliveira et al., 2014; Muthuraju et al.,
2014). As a neuromodulator, DA in the CN aﬀects T-type Ca+2
channels at the axon initial segment (Bender et al., 2012). Roles
for DA in the IC remain to be determined, but several studies
suggest a role for DA in the response to aversive stimuli. In the
current study, cochlear damage results in signiﬁcant changes in
gene expression for TH in both the CN and the IC. The close
association of TH with GAD67, GLYT2, VGLUT1 as well as
VGLUT3 places DA in a position to inﬂuence the balance of
excitation and inhibition in the CN and IC, prior to and after
hearing loss.
Genes Related to Dopaminergic and Amino
Acid Neurotransmitter (AAN) Effects in the CN
and IC are Differentially Expressed Following
Deafness
The deafness related changes in gene expression observed in the
CN showed a diﬀerent magnitude and time course of change
when compared to changes observed in the IC (summarized
in Tables 1 and 2). For TH deafness related decreases in gene
expression in the CN were only observed at the 2-months time
point. Of the AAN related genes, only two genes showed deafness
related changes with a similar time course as TH, GLYT2,
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FIGURE 14 | In the IC VGLUT3 is distributed throughout each
subdivision. Although some labeling is observed in terminals, the majority of
labeling for VGLUT3 is contained within somata and dendrites (A–C). In the
CNIC large and small multipolar neurons with round somata and proximal
dendrites are labeled for VGLUT3 (A,A’). While prominent somatic labeling for
VGLUT3 is found in the ECIC (B,B’) and DCIC (C,C’) localized to small
elongated neurons with little to no labeling of proximal dendrites (arrowheads)
as well as within larger neurons, including proximal dendrites (arrows). CNIC –
central nucleus of the IC; ECIC – external cortex of the IC; DCIC – dorsal
cortex of the IC; Scale bars: 20 μm.
and GABAtp. Glycine and GABA are the major inhibitory
neurotransmitters in the CN. The GABA transporter protein,
GABAtp removes GABA from the synaptic cleft. Likewise,
the glycine transporter, GLYT2, functions to take up released
glycine. The distribution of GLYT2 has been described in the
CN and IC (Zafra et al., 1995; Friauf et al., 1999) If levels
of these transporters decrease, as in the current study, then
GABA and glycine may remain active in the synapse for
FIGURE 15 | In the DCIC VGLUT3 (green) and TH (red) are co-localized
in somata and dendrites (A–F). In the DCIC double labeling for VGLUT3
and TH was primarily observed in somata and dendrites. Arrows indicate
somatic and dendritic labeling for VGLUT3 and TH. The asterisks indicate
neurons in the DCIC labeled only for VGLUT3. DCIC – dorsal cortex of the IC;
Scale bars: 10 μm.
longer periods resulting in compensatory decreases in production
presynaptically. Ototoxicity resulting in profound hearing loss
diminishes glycine labeling in the CN (Buras et al., 2006).
In agreement with previous studies (Holt et al., 2005; Tong
et al., 2005), following deafening, decreases in TH expression
within the IC were evident early and sustained. This change
in TH expression correlated with sustained changes in gene
expression for GABAergic markers (GABAtp and GAD67), and
glutamatergic markers (VGLUT2 and VGLUT3). Interestingly,
unlike the CN, in the IC there were no acute changes in
expression that were not sustained at the later time point
(Tables 1 and 2). Also, DA receptor expression at the 3 days
deaf time point had the largest SD when compared to other gene
expression changes tested in the IC. Increased variability in DA
receptor expression observed after 3 days of deafness may reﬂect
a period of instability in DA receptor expression during the time
immediately after cochlear ablation. Perhaps this initial period
of hearing loss creates ﬂux/plasticity and diminished DA levels
as a new homeostatic set point is established. Together, these
correlated changes in gene expression suggest that changes in DA
levels may modulate neurotransmission in both the CN and IC
following deafness.
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TABLE 2 | Gene expression and immunocytochemistry comparison in the cochlear nucleus (CN).
Cochlear Nucleus
PCR ICC
Genes 3 days 2 months 2 months 2 months 2 months 2 months 2 months
Subdivision CN CN AVCN-C AVCN-Gr DCN-M DCN2-F DCN-D




GAD67 – – – ↑ ↑ ↓ ↓
GLYT1 – –
GLYT2 – ↓ – – ↓ ↓ ↓








(a) Up arrow – Increased levels. (b) Down arrow – Decreased levels. (c) Dashes – No Change. (d) Empty – Not assessed.
TABLE 3 | Gene expression and immunocytochemistry summary in the inferior colliculus (IC).
IC
PCR ICC
Genes 3 days 2 months Normal hearing Normal hearing Normal Hearing
Subdivision/Genes IC IC CNIC DCIC ECIC
VGLUT1 + + +
VGLUT2 ↓ ↓
VGLUT3 ↓ ↓ + + +
GAD65 ↓
GAD67 ↓ ↓ + + +
GLYT1 ↓









TH and AAN Related Proteins in the CN are
Closely Associated
In the CN, glycine and GABA positive terminals are in close
contact with TH positive terminals and dendrites, providing an
opportunity for DA to inﬂuence the release or the eﬃcacy of
glycine and GABA that has been released. Immunocytochemistry
for TH and VGLUT1 in the AVCN reveal labeling primarily
in puncta for VGLUT1 and in puncta and dendrites for TH.
Following deafness the localization of VGLUT1 labeling shifts
from labeling of puncta to labeling of both puncta and somata.
However, localization of TH labeling does not appear to change
following deafness, but the labeling (intensity and number of
elements) is decreased. In the DCN heavy labeling for VGLUT1
is found in DCN-M with sparse labeling in DCN-F and DCN-D
of the DCN. Labeling for TH in the DCN is found in each layer.
Following deafness, VGLUT1 labeling is decreased in layer 2 and
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layer 3. There are also deafness related changes in TH labeling
with increased labeling in DCN-M and decreased labeling in
DCN-F and DCN-D. Immunocytochemistry for GAD67 shows
labeled puncta, primarily associated with somata, throughout
the AVCN, with prominent labeling of terminals in layer two
of the DCN. Deafness results in an increase in GAD67 labeling
in the granule cell region and labeling is no longer associated
primarily with somata. In the DCN GAD67 labeling is increased
in DCN-M and DCN-F. Immunolabeling for GLYT2 in both
the AVCN and DCN is localized to terminals with labeling in
the AVCN associated with somata and labeling in the DCN
most prominent in DCN-F. After 2 months of deafness, labeling
decreases throughout the AVCN and in DCN-M and DCN-
F. In the CN markers for both DA and AAN related genes
decrease and there are changes in the localization as well
as decreases in the number and intensity of immunolabeled
neuronal elements as a consequence of deafness. While TH
appears to be closely associated with AANs in the CN, synapsing
with TH labeled processes, there appears to be very little if
any co-localization. Although there are deafness related changes
in synaptic organization, the opportunity for DA release to
impact CN neurons still exists, given the close proximity of TH
labeled varicosities. The impact of diminished DA release in
the CN could be many fold and would depend not only upon
other neurotransmitters at the synapse, but also the type of DA
receptor present. In the CN, recent studies suggest D3 mediated
modulation of T-type calcium channels can shape spontaneous
neuronal activity (Bender et al., 2012). This correlates well with
the current study in which DRD3 gene expression is signiﬁcantly
decreased after hearing loss. Although the gene expression studies
included the entire CN, these results provide clues as to the cell
type that may be contributing to changes since cartwheel cells
produce calcium channels at the axon initial segment that are
modulated by DA (Bender et al., 2012) and have reduced glycine
levels following deafness (Buras et al., 2006).
While IC Somata Co-Localize TH and either
GLYT2 or VGLUT3, Terminals in the IC are
Immuno-Positive for either TH or AAN Related
Proteins, which are in Close Proximity to One
Another
Previously, DA positive terminals and receptors have been
reported throughout the auditory pathway, including the IC
(Wamsley et al., 1989; Weiner et al., 1991; Kitahama et al., 1996;
Tong et al., 2005; Goodson et al., 2009; Bender et al., 2010;
Kubikova and Kostal, 2010; Kubikova et al., 2010; Maison et al.,
2012). DA in the IC has been shown to have functional relevance.
Introduction of DA agonists and D2 receptor antagonists into
the IC results in modulation of the acoustic startle reﬂex (Satake
et al., 2012), noted for use in human studies and animal models
of psychiatric illness (Swerdlow et al., 2008). Pre-pulse inhibition
of the acoustic startle reﬂex, has more recently been adapted
(gap inhibition of the acoustic startle reﬂex) and used in the
study of tinnitus (Turner et al., 2006; Holt et al., 2010; Fournier
and Hebert, 2012). In the DCIC, ECIC and the CNIC of the IC
immunolabeling for vesicular glutamate transporter 3 (VGLUT3)
as well as TH is localized to somata, dendrites and puncta.
Following deafness TH labeling decreases throughout the IC,
but VGLUT3 immunolabeling shows no change. The labeling
for TH and VGLUT3 is co-localized throughout the IC with
the most distinct labeling in the DCIC. Labeling for GLYT2 is
observed in somata, dendrites and puncta throughout the IC
and also co-localizes with TH. Therefore, with TH produced
and presumably released from neurons that also produce either
glutamate or glycine, TH is positioned to inﬂuence the eﬀect of
the neurotransmitter released from these neurons. In addition,
many TH positive processes are in close contact with AAN
containing processes and could, therefore, impact excitability
depending upon the type of postsynaptic DA receptors present.
Conclusion
Deafness results in sustained changes in gene expression for
AAN related genes in the CN and the IC with the IC
exhibiting more sustained changes. Several of these genes
demonstrated decreased expression on a timescale similar to
that of TH. Studies demonstrating TH positive ﬁbers in the
CN and IC that do not label for DBH are suggestive of
DA release in these regions. This idea is further supported
by in situ studies showing the localization of DA receptor
related genes in the CN and IC. The current study adds to
the suggestion of endogenous DA in auditory pathways by
demonstrating deafness related changes in both D1 and D2
type receptors. DA may therefore play a role in modulating
neurotransmitter release in both the CN and IC and/or eﬃcacy
of glutamatergic and glycinergic projections from IC neurons.
These studies lay the groundwork for future studies on the
eﬀects of DA modulation on the release of AANs in the CN
and IC.
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